1Antitumor activity of the oncolytic adenovirus SG600-p53 in gastric cancer xenografts in nude miceARTICLES193-195
2The expression and clinical significance of CD4+CD25high regulatory T cells and Foxp3 mRNA in advanced esophageal cancer patients pre-treated and treated with chemotheraphyARTICLES196-198
3Expressions of FAK,FAK pY397,Akt and NF-κB in colorectal carcinomas and study on their correlationARTICLES199-202
4Research on changes of PIP mRNA expression in the peripheral blood of patients with breast cancer before and after adjuvant chemotherapyARTICLES203-206
5Expression and significance of hypoxia-inducible factor-la and glucose transporter protein-1 in epithelial ovarian tumorARTICLES207-211
6The expression and clinical significance of FHIT protein and mdm2 protein in non-small cell lung cancerARTICLES212-216
9The change of T-lymphocyte subsets during the perioperation in the elder patients with esophageal carcinomaARTICLES225-228
10Effect of the three digestive tract procedures after total gastrectomy on postoperative quality of lifeARTICLES229-231
11Clinical study of carmofour combined with three-dimensional conformal radiotherapy for esophageal carcinomaARTICLES232-234
12Blood serum concentrations of vascular endothelial growth factor and survivin in adult patients with acute lymphoblastic leukemiaARTICLES235-237
13The clinical value of multiple tumor marker protein chip system in evaluating recidivation of colorectal cancerARTICLES238-241
14Experiences on the surgical treatment of sacrococcygeal teratoma in childrenCLINICAL PRACTICE242-244
15Clinical observation for radiotherapy concurrently combining with nedaplatin in the treatment of advanced esophageal carcinomaCLINICAL PRACTICE245-246
16FOLFOX4 combined with intraperitoneal perfusion FUDR for gastric signet-ring cell carcinoma with metastasis tumor of abdomenCLINICAL PRACTICE247-248
17Analysis of the infectin-related factors of subclavian central venous catheter for 2 102 tumor patientsCLINICAL PRACTICE249-251
18Intraperitoneal injection of recombinant human endostatin combined with fluorouracil on advanced cancers with malignant ascitesANTI-ANGIOGENESIS STUDY252-255
19Recombinant human endostatin combined with chemotherapy in treatment of advanced malignant tumorsANTI-ANGIOGENESIS STUDY256-258
20Experts consensus of standard diagnosis and treatment in primary liver cancerGUIDELINE INTERPRETATION259-269
